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Abstract
Background: “Low dead space” syringes with permanently attached needles retain less fluid, blood, and HIV after
use than standard “high dead space” syringes. This reduces the probability of HIV transmission if they are shared by
people who inject drugs (PWID). The World Health Organization recently recommended that needle and syringe
programs (NSP) offer clients low dead space syringes. The success of this recommendation will depend on PWID
switching to low dead space needles and syringes. This paper examines the needles and syringes that PWID in
Tajikistan use and factors that influence their choices.
Methods: In May 2014, we conducted six focus groups in Kulob and six in Khorog, Tajikistan, with a total of 100
participants. NSP staff members recruited participants. Focus group topics included the needles and syringes used
and factors that influence choice of needles and syringes. Focus groups were conducted in Russian and Tajik, audio
recorded, transcribed, and translated into English. The translated files were imported into NVivo 10 for coding
and analysis.
Results: All participants in both cities were male and reported injecting heroin. Everyone also reported using syringes
with detachable needles almost exclusively. The most popular syringe sizes were 2 and 5 ml. Needles ranged in gauge
from 25 to 21 g. Needle gauge was influenced by the size of the vein, the viscosity of drug solution to be injected, and
problems with blood clotting. Needles ranged in length from 12 to 38 mm, with 25 and 32 mm being the most popular.
Needle length was influenced by the depth of the vein being used. Many PWID inject volumes of fluid greater than 1 ml
into deep veins that require needles at least 25 mm long and 25 g in diameter.
Conclusion: Most low dead space syringes are 1-ml insulin syringes with 12 mm 28 g permanently attached needles.
Findings from this project suggest that these will not be acceptable to PWID who need larger syringes and longer and
thicker needles that are detachable. Low dead space detachable needles appear to be an acceptable option that could
overcome barriers to the widespread use of low dead space equipment for reducing HIV and HCV transmission.
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Background
HIV and hepatitis C virus (HCV) are serious problems
in Tajikistan and other Central Asian Republics among
people who inject drugs (PWID) [1, 2]. Most HIV and
HCV infections among PWID are attributed to direct
needle and syringe sharing (i.e., multi-person use of a
needle and or syringe) [3, 4] or indirect sharing (i.e.,
sharing drug preparation materials or the liquefied drug
solution) [5, 6]. PWID use a variety of different needle
and syringe combinations [7]. Some needles and syringes
retain visibly more fluid and blood (i.e., “high dead
space” syringes) after they have been used than other
needle and syringe combinations retain [8, 9]. Syringes
that retain less blood have been referred to as “low dead
space” syringes [10, 11]. In laboratory tests, HIV and
HCV survived longer in high dead space syringes than in
low dead space syringes [12, 13]. Evidence from a variety
of sources suggests that the probability of HIV and HCV
transmission associated with exposures that involve high
dead space needles and syringes is greater than the prob-
ability of transmission associated with exposures involv-
ing low dead space needles and syringes [11]. This raises
the possibility that getting PWID to use only low dead
space needles and syringes could reduce injection-
related HIV and HCV transmission even if they contin-
ued to engage in unsafe injecting practices at the same
rate [14]. Circumstantial evidence in support of this ob-
servation led the World Health Organization (WHO) to
include a recommendation for needle and syringe
programs to offer their clients low dead space syringes
[15]. The impact of this recommendation will depend on
the willingness of PWID to use only low dead space nee-
dles and syringes [10].
Figure 1a illustrates the dead space in a standard nee-
dle and syringe. The first low dead space syringes, which
were insulin syringes, had a permanently attached needle
that extended through the nozzle of the syringe to the
base of the barrel (Fig. 1b). To this day, virtually all sy-
ringes with permanently attached needles are low dead
space. Until relatively recently, syringes with detachable
needles have all been high dead space. However, this
situation is changing. Some syringes have an elongated
tip on the plunger that extends into the nozzle of the
syringe (Fig. 1c). This eliminates almost all of the dead
space in the nozzle of the syringe; however, it does not
affect the dead space in the hub of the needle. Some
needles are also designed to reduce dead space. These
needles have a spike that extends into the nozzle of the
syringe (Fig. 1d). These needles can eliminate most of
the dead space in the hub of the needle and in the noz-
zle of the syringe. The actual reduction in dead space
achieved by these low dead space detachable needles
varies from syringe to syringe. This is because there
are no standards for the wall thickness and height of
syringe nozzles.
The characteristics of needles and syringes are likely
to influence the probability of HIV and HCV transmis-
sion if they are shared. Nevertheless, relatively few
Fig. 1 Cross-sectional view illustrating dead space in standard needles and syringes and low dead space options. a Standard needle on standard
syringe; b Low dead space syringe with permanently attached needle; c Standard needle on low dead space syringe; d Low dead space needle
on standard syringe
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studies of PWID have examined the characteristics of
the needles and syringes that PWID use or the factors
that influence their choice [7, 16]. These few studies in-
dicate that PWID use needles that vary in length and
gauge (i.e., outside diameter). The syringes that PWID
use vary in barrel capacity and in whether the needles
are permanently attached or detachable. In addition to
the design (i.e., high dead space or low dead space), syr-
inge barrel capacity, needle length, and needle gauge all
influence dead space volume in a needle and syringe
combination [17].
This paper explores the factors that influence the
length and gauge of needles, the barrel capacity and de-
sign (i.e., fixed needle, detachable needle) of syringes that
PWID in Tajikistan prefer and use. The paper also
examines the interrelationships among these factors and
their implications for efforts to transition PWID from
high dead space to low dead space needles and syringes.
Methods
This paper reports findings from focus groups that were
conducted during the formative phase of a project to
develop and pilot test an intervention to transition NSP
clients from standard (high dead space) needles and
syringes to low dead space needles and syringes. We
selected Tajikistan based on findings from a previous
project. In that project, NSP in 70 cities and 30 coun-
tries across Europe and Asia completed a brief survey
regarding local HIV prevalence among PWID, the main
drugs injected locally, the characteristics of the needles
and syringes that they distributed, and several other
issues [11, 17].
Recruitment and eligibility
In May 2014, we conducted 12 focus groups (6 in Kulob
and 6 in Khorog) with a total of 100 participants (47 in
Khorog and 53 in Kulob). Participants were recruited by
needle and syringe program (NSP) staff members either
at the NSP offices or while doing outreach. The focus
groups were conducted in the NSP office in each city.
Eligibility criteria included a minimum age of 18 years,
self-reported injection in the previous 30 days, obtaining
syringes from the NSP at least two times in the last
30 days, and the ability to speak Tajik or Russian.
Focus group procedures
The focus groups were conducted by two trained facilita-
tors and attended by two observers (the Principal Investi-
gator and the local Project Coordinator). The focus group
guide explored the following topics in detail: substance
use patterns, injecting drug use practices, types of needles
and syringes used, reasons for using specific types of nee-
dles and syringes and their combinations, syringe cleaning
procedures, sources of injecting equipment. Each focus
group lasted between 60 and 90 min, was digitally re-
corded and transcribed directly into native language. All
transcripts were translated into English to permit review
and discussion with US collaborators.
The study received ethical approval from the Commit-
tee of Medical Ethics of Tajikistan and the RTI Interna-
tional’s Office of Research Protection. All participants
provided oral informed consent, and received the
equivalent of $5 US for their participation.
Analysis
NVivo v.10 (http://www.qsrinternational.com/products_n-
vivo-mac.aspx) was used for the qualitative content and
thematic analysis. The transcripts were not back-
translated, since one of the coders (also one of the co-
authors), fluent in Russian, Tajik, and English languages,
constantly compared English translation with the original
version. In addition, another co-author, also fluent in all
three languages, reviewed translation and analysis findings
to ensure they adequately reflected the original language
transcription. Coders were two individuals experienced in
qualitative research and familiar with the drug scene and
overall cultural context of Tajikistan. Coders read and re-
read the transcripts and developed a draft code book with
major categories, sub-categories, and codes based on the
topics in the FGD guide. To ensure consistency and simi-
larity of coding, each coder independently coded two tran-
scripts (one per study site), then compared, discussed, and
revised codes and the code book. Further, each coder inde-
pendently coded all remaining transcripts. Coders itera-
tively communicated and discussed all revisions to the
code book, including addition of new codes, grouping and
regrouping of codes and categories in the coding tree until
an agreement was reached. After completion of the coding
process, inter-rater reliability coefficient was calculated.
Once a certain code had been created in NVivo, it was
then applied in relevant places in other interviews. Thus,
we had a set of nodes (codes), with reference and source
numbers. During reading of transcripts, notes, memos and
annotations were done; then, linkages/relationships be-
tween relevant statements were created. In the final stage,
the two independent sets of codes of these coders were
merged to track the contributions of different raters and to
compare coding as a way of facilitating common ap-
proaches across coders. Coder Comparison Analysis pro-
vides information about code type, code, source type,
source, and source folder. Two measures of agreement
[18] between coders were calculated in NVivo [19]:
▪ Percentage agreement [20] is calculated from the
number of units (usually characters) for which two
coders are in agreement (including both presence and
absence of coding for the particular node), compared to
the total number of available units.
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▪ The Kappa coefficient [21] is a statistical measure of
the level of agreement between two coders that takes
into account the amount of random (chance) agreement
that could be expected to occur.
The Kappa coefficient and percentage agreement were
calculated individually for each combination of nodes
and sources and for all nodes together. The results of
this coding comparison query were exported from
NVivo as an excel spreadsheet (using the Export List
command). The average agreement rate by source size
(characters) and weighted Kappa coefficient for all nodes
were calculated using Excel formulas resulting in 99.69
and 0.83 %, respectively. The results of separate calcula-
tions of Kappa coefficient of key nodes and percentage
agreement can be seen in Table 1.
According to results of coding comparison, we would
conclude that the inter-rater reliability is excellent [22],
because the obtained Kappa is higher than commonly
applied criteria of 0.81 [23].
Description of the sample
All participants were male. The mean age was 42 years
(median = 43 years). Participants reported injecting an
average of 15 times per week (range 1–35). Most (75 %)
of participants reported that the NSP was their primary
source of needles and syringes. An additional 13 % re-
ported obtaining equal percentages of needles from NSP
and other sources, and 9 % reported pharmacies as their
primary source of needles and syringes. Participants
reported obtaining syringes from the NSP an average of
12 (range 2–30) times in the last 30 days.
Results
Drugs used
All participants in both cities reported injecting heroin
from Afghanistan. Kulob is approximately 70 km from
Afghanistan, and Khorog is situated on the Tajik side of
the Panj River, which separates Afghanistan and
Tajikistan. The price of a gram of heroin cited by the
majority of respondents in Khorog was 50 Somoni, the
equivalent of $10 US. In Kulob, the average price of her-
oin was 50 Somoni, approximately $10 US, a gram.
However, participants reported that prices in Kulob
often fluctuate, and higher purity heroin may sell for 100
Somoni ($20 US) per gram. There was a general
perception that the heroin currently being sold in both
cities was not as pure as the heroin that was available in
previous years. This may reflect an actual decline in the
quality of heroin, or their perceptions may be clouded
by nostalgia. Several participants reported that the drug
sellers adulterated heroin with zopiclone or diphen-
hydramine. Zopiclone is from the same family of drugs
as Lunesta (eszopiclone) and Ambien (zolpidem).
Diphenhydramine is an antihistamine, which reports in-
dicate has been mixed with heroin and injected in other
settings [24]. Participants in Kulob reported that some
PWID add diphenhydramine to heroin after they
purchase it to potentiate the effects of the heroin when
there is a shortage.
“If heroin is pure, it will carry you away until the
morning, you won’t feel sick. But there is shortage of
[good quality] heroin now, that’s why they shoot it
[mixing with medicines].” (FGD#3, Kulob)
Several participants in Khorog reported that some
PWID inject “khanka” (i.e., acetylated opium). They said
“khanka” is produced by adding acetic anhydride to
opium. However, “khanka” injection is relatively uncom-
mon now because heroin is readily available in Khorog.
Some participants in Kulob reported injecting “synthetic
heroin” in the past. One participant described the differ-
ence in the appearance of heroin and “synthetic heroin”
as follows:
“Usually heroin has no glitter, but that one glitters like
glass, it is a substitute, you buy it for the same money,
the price is the same.” (FGD#1, Kulob)
They reported that this “synthetic heroin” was sold
on the market several years ago and was associated
with a higher risk of overdose. No one was sure of the
chemical composition of this “crystal heroin.” Most
participants reported that they would only buy it if
regular heroin was not available.
One participant in Kulob reported that some people
who inject heroin inject eye drops that contain tropica-
mide to relieve withdrawal symptoms if they cannot get
heroin. However, no other participant mentioned it, so
this practice did not appear to be widespread in Kulob
or Khorog at the time these focus groups were conducted.
Table 1 Results of calculation of average Kappa coefficient and percentage agreement across sources and nodes
Node name Kappa (weighted) Agreement (%)
Good quality needle and syringe 0.76 99.83 %
Bad quality needle and syringe 0.88 99.91 %
Used combinations of needles and syringes 0.73 99.72 %
Overall evaluation of low dead space syringes 0.91 99.95 %
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Factors that influence the characteristics of needles and
syringes that are used and preferred
Most of the participants differentiate the needles by
length and thickness; nobody mentioned needle gauge as
the way to distinguish between the needles. Many partic-
ipants distinguish needles by the color of the needle hub
and according to volume of the syringe the needle usu-
ally comes with (e.g., the needle of a 2-ml syringe, the
needle of an insulin-type syringe etc.). Needle hubs are
color coded by gauge. However, in a previous study, we
found that the color coding is not consistent across all
manufacturers [17].
Quality of needles
Participants prefer needles that are sharp and that are
securely attached to the plastic hub. Needles are mass-
produced, and all manufacturers occasionally produce
needles that are defective. These defects include needles
that are dull, bent, or poorly secured to the plastic hub
when they leave the manufacturer. Most PWID prefer
needles that are sharp because they are less painful, and
they do less damage to veins. The proportion of defect-
ive needles from the NSP in Khorog seemed to have
increased recently.
“Well, they are blunt, expired. Before, when it started,
everything was ok, beautiful, needles were clean and
fine, not expired, and now, recently, they are all blunt
and of low quality. OK, but if we don’t take it, then
what we will shoot with?” (FGD#8, Khorog)
Several participants reported that when some needles
are reused multiple times, the connection between the
needle and the needle hub fails, and the needle detaches
and remains in their arm following the injection.
Although this seems to be a relatively rare occurrence, it
seems to make an impression on PWID when it happens
as described by a participant from Khorog.
“The needle does not break; it just comes out of there,
out of the plastic thing.
Old ones, expired ones.” (FGD#8, Khorog)
Needle length
Needle length varied depending on the injection site/
vein. Medium-length (25 mm) needles were preferred by
those participants who inject into cubital (i.e., forearm
or elbow) veins. Some of the participants mentioned that
they use 25-mm needles for injecting into the neck. Lon-
ger (32 mm) needles are used for injecting into the groin
or femoral veins. Some participants reported that PWID
combine 2-ml syringes with larger needles from 5- or
10-ml syringes to inject into the groin as illustrated in
the following quotes.
“Those who shoot in veins, they use 25 [mm needles],
and there are people who shot into groin, that use 32
[mm].” (FGD#10, Khorog)
“If someone has large veins, good veins, he would use
small [needles]. And those, as someone said, hopeless
ones, who shoot into groin, they hit with [needles from]
5-ml [syringes]. If there are no veins, only tiny veins
are left, he would use insulinka [needles from insulin-
type syringes].” (FGD#5, Kulob)
“I take these 2-ml [syringes], but would attach a longer
needle, the blue one or the black, long one, which [syringe]
had those? Was it 10-ml? So this kind of needle, I buy
them, will tear [the package] off, I throw [the barrel]
away, will take its’ needle and will attach it to a 2‐ml
[syringe].” (FGD#6, Kulob)
Longer needles are also preferred by those who inject
intramuscularly or into deep (central) veins
“…yes, [intra]muscular, so [the solution] will not go
under the skin. Because, if [the needle] is [short], [the
solution] will go under the skin.” (FGD#8, Khorog)
“It will not work then, it is too short, it will reach only
so much, will not reach central veins. So I would use
[a needle from a] 2-ml one… it can reach the central
veins…].” (FGD#5, Kulob)
Using longer needles to inject in shallow veins raises
the risk of going all the way through the vein and into
tissue beneath the vein. In some instances, this may
cause bruising and discomfort, and in other instances, it
may lead to abscesses or other soft tissue infections. So,
most PWID try to avoid using longer needles to inject
into shallow veins.
Needle gauge
As noted previously, the gauge of a needle is its out-
side diameter. The diameter of the bore of needles of
the same gauge may vary depending on if the needle
is thin walled or thick walled. Higher gauge (i.e., thin-
ner) needles are preferred for injecting in the smaller
veins of the arms or hands. In particular, a needle
from the insulin-type syringe (also called a “capillary”
needle) is very popular for injecting into thin veins
(referred to as capillaries by some of the participants).
Some participants mentioned that insulin-type needles
can be used for injecting into the surface veins in
arms and hands by PWID who have good veins, in-
cluding those who recently started injecting. PWID
often combine the needle from an insulin-type syringe
with a barrel from a 2-ml syringe.
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“If someone has visible veins, he would, of course, use
insulinka, it has a small needle.” (FGD#8, Khorog)
“I have these [insulin-type syringes], it has a thin needle,
why do you use them, so the vein does not burst, no blood
gets deposited there. [Insulin-type syringes], they have
very small needles, so with that, it is a little bit easier
with it. You check [if the needle is in the vein], you inject,
smoothly. Say, I have no large veins, lost them, so I use
insulinka for thin veins.” (FGD #4, Kulob)
These needles are also preferred by those who want to
avoid visible needle puncture marks on their skin, which
may reveal that they inject drugs. Injecting with thin
needles from insulin-type syringes is also less painful.
“… it is better with that [needle from an insulin-type
syringe], because it will not leave needle traces, needle
marks…No bruises.” (FGD #3, Kulob)
“…I just hit with insulin-[type syringe], so it does not
hurt.” (FGD#5, Kulob)
Participants reported that PWID often use thicker nee-
dles when they are injecting in larger veins. They reported
preferring thicker needles if they were injecting more vis-
cous fluids that are difficult to inject through a thin needle.
Similarly, participants reported that PWID who have
trouble with their blood clotting and clogging the needle
prefer thicker needles because they do not clog as easily.
Participants in both cities reported these issues as described
in the following quotes.
“Those who use a filter, they can use thin ones, it won’t
[get clogged] thanks to filtering. For us it won’t work,
because most just shake [drug mixture inside the
syringe], so it is not good for us.” (FGD#5, Kulob)
“With the brown [hub] needles, say, when you draw
the blood in, if you are a bit late, it can get clogged.”
(FGD#4, Khorog)
“[Needles from insulin-type syringes] or others, 46th,
25th, if you use them, they get clogged, it happens…”
(FGD#7, Khorog)
In general, needles longer than 25 mm tend to be
thicker because long thin needles bend too easily. PWID
who inject in femoral veins or other deep veins require
long thick needles to reach the vein without bending.
Needle hub opacity
Several participants reported that they preferred needles
with translucent plastic hubs over needles with opaque
plastic hubs. With a translucent hub, PWID can see the
blood when it is still in the needle hub. With an opaque
hub they have to draw blood all of the way into the
barrel of the syringe as described in this quote from a
participant in Khorog.
“…you would draw blood back and will not see it, you
won’t know if the needle is there [in the vein] or not.”
(FGD#12, Khorog)
Drawing more blood into a syringe increases the possi-
bility that the blood may clot and block the needle. As
blood disperses through the drug solution, the solution
begins to look like blood. This can be problematic if the
needle moves slightly during the injection process, and
more blood needs to be drawn into the syringe to con-
firm that the needle is still in a vein. Opaque needle
hubs also make it impossible to tell if there is blood
trapped in the hub of the needle after rinsing a syringe
with the needle attached. With an opaque needle hub,
the only way to determine if blood is still in the needle
hub is to remove the needle and look into the hub.
These factors may increase the risk of blood borne dis-
ease transmission if needles with opaque needle hubs
are shared.
Syringe barrel capacity
Participants reported that the barrels of 1-ml syringes
are long and thin. Using these syringes, it is difficult to
operate the plunger with one hand when injecting vol-
umes of fluid much greater than 0.5 ml. A participant
from Khorog described the problem as follows:
“[The insulin-type syringe] is somehow inconvenient, it
is small and thin, and it is easier with a 2[ml], with
this one, it is easier to handle it with one hand.”
(FGD #12, Khorog)
When injecting into a vein in an arm or hand, it is es-
sential to hold the syringe steady with two fingers and a
thumb and operate the plunger with the index finger
and the middle finger.
Some homemade drugs require injecting volumes of
fluid greater than 2 ml. Also, when PWID are preparing
drug solutions for more than one person, they may use
5-ml syringes.
Syringe design (permanently attached or detachable needle)
Many PWID reported preferring syringes with detach-
able needles over syringes with permanently attached
needles. In some instances, this was because the max-
imum barrel capacity of syringes with permanently at-
tached needles in Tajikistan is 1 ml. As noted
previously, the barrels of most 1-ml syringes are long
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and thin. This makes them difficult to manipulate with
one hand if a PWID is injecting more than 0.5 ml of
fluid, and most PWID in Tajikistan inject at least 1 ml
of fluid. In addition to not being available in the appro-
priate barrel capacity, participants reported several
other reasons for preferring detachable needles. If a de-
tachable needle clogs, it is relatively easy to remove it
and replace it with another needle. With detachable nee-
dles, the needle can be removed, and the tip of the syringe
nozzle can be placed directly on the filter. The bore of the
syringe nozzle is much larger than the bore of a needle,
which allows even high viscosity solutions to be drawn up
relatively rapidly. Another potential benefit that was not
mentioned is that removing a needle when drawing the
drug solution into the syringe virtually eliminates the risk
of dulling a needle by accidentally jamming it into the bot-
tom of the mixing vessel (e.g., cooker, spoon).
Discussion
A wide variety of interrelated factors influence the char-
acteristics of the needles and syringes that PWID prefer
and use. These focus groups provided rich information
on the characteristics of the needles and syringes that
PWID use and the factors that influence the use of dif-
ferent needles and syringes. We used this information to
construct a diagram of the interrelationships among the
different factors (Fig. 2).
Factors, such as a preference for high quality needles
and syringes or for translucent needle hubs are likely to
remain relatively stable over time and are relatively inde-
pendent of each other. In contrast, the factors that influ-
ence choice of needle gauge, needle length, syringe
barrel capacity, and syringe design (i.e., permanently at-
tached needle or detachable needles) tend to be interre-
lated and more variable. Factors such as the condition of
Fig. 2 Factors that influence choice of needle gauge, needle length, and syringe barrel capacity and interrelationships among them
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a person’s veins are likely to evolve over time. Over the
course of an injection career, veins get worse. Other fac-
tors, such as syringe barrel capacity may be situational
and change depending on the volume of fluid required
to prepare a specific drug (e.g., heroin, acetylated opium)
or whether the drug solution is prepared for one person
or to be divided among two or more people.
It appears that because most PWID in Tajikistan inject
heroin almost exclusively, there is less variation in syr-
inge barrel capacity than in cities and countries where
PWID inject a variety of drugs [7]. Although most
PWID in Khorog and Kulob use 2-ml syringes, some
also use 5-ml syringes. According to the participants in
these focus groups, almost no PWID in Tajikistan use
1-ml or 10-ml syringes. In a previous study, we found
that the dead space in a needle and syringe combin-
ation increased as the barrel capacity increased [17].
This association also holds up when low dead space de-
tachable needles are attached to syringe barrels of dif-
ferent capacity. This may make low dead space detachable
needles more effective in reducing the probability of HIV
and HCV transmission in Tajikistan than in countries such
as Ukraine where larger (e.g., 5 ml and 10 ml) syringes are
more common [7].
There was much wider variation in terms of needle
length and needle gauge. Participants described factors such
as injection site, viscosity of the drug solution, and need to
conceal injection marks that influenced needle length and
gauge. Nevertheless, they reported that they would use
whatever needle was available when they were injecting.
These findings suggest that low dead space detachable
needles will be acceptable to PWID in these cities as
long as they are high quality and available in the appro-
priate lengths and gauges.
Limitations
As with most qualitative research, the generalizability of re-
sults may be limited. All of the participants in the focus
groups reported obtaining some or all of their needles and
syringes from NSP. Accordingly, the results may not be
generalizable to PWID who do not obtain syringes from
NSP. In addition, the focus group participants were not
randomly selected from NSP participants, so the findings
may not be generalizable to all NSP clients in each city.
Nonetheless, the PWID in these focus groups were similar
to PWID who participated in integrated bio-behavioral sur-
veys (IBBS) in these cities [1]. The absence of women in the
focus groups also limits the generalizability. Although the
vast majority of PWID in Tajikistan appear to be male, in
some other countries women make up a substantial pro-
portion of PWID. However, to the extent that women inject
with men, they are likely to be injecting the same drugs,
using the same needles and syringes and facing some of the
same injection-related problems [25]. PWID in other cities
in Tajikistan may differ from PWID in Kulob and Khorog.
So, caution should be used in generalizing these findings to
PWID in other cities.
In reporting findings from focus groups and qualitative
interviews, the inclusion of direct quotes from participants
adds richness to the results. However, these focus groups
were conducted in Russian and Tajik and translated into
English for analyses. Although the translations and main
analyses were performed by researchers who are fluent in
all three languages, translated quotes may lose some of
the cultural nuances from the original quote.
We did not ask participants if they usually obtained a
variety of needles and syringes from the NSP or phar-
macy or if they only obtained a single size. It seems
likely that many PWID may only ask for the specific
needles and syringes that they prefer and use instead of
asking for a variety of needles and syringes. In instances
where PWID inject together, they inject in different
veins/injection sites, but if only one of them has needles
and syringes, the other may be forced to use a needle
and syringe combination other than he or she prefers.
Conclusion
Findings from this study suggest that efforts to promote
low dead space syringes may fail if they rely solely on 1-ml
insulin-type syringes with permanently attached needles.
This is especially true in places like Tajikistan where al-
most all PWID use 2-ml or larger syringes and prefer de-
tachable needles. However, low dead space detachable
needles may provide an acceptable alternative in these
areas, which could greatly expand the impact of low dead
space needles and syringes on reducing HIV and HCV
among PWID globally.
It is important for policy makers and those responsible
for NSP purchasing decisions to ensure that NSP distribute
high quality needles and syringes with attributes (e.g., barrel
capacity, needle length, needle gauge) that are acceptable to
NSP clients. Prior to implementing the WHO recommen-
dation to offer their clients low dead space needles and sy-
ringes, NSP need to ascertain the needs of their clients and
offer low dead space equipment that will be acceptable to
their clients. To ensure uptake of low dead space equip-
ment, NSP may also have to provide educational and mo-
tivational materials regarding the benefits of switching to
low dead space needles and syringes.
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